Fresenius Medical Care AG & Co. KGaA (FMS) — Financial statements
Income statement, balance sheet, and cash flow for Fresenius Medical Care AG & Co. KGaA — annual and quarterly history with growth and margin analysis.
| Metric (EUR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 19,628↑1.5% | 19,336↓0.6% | 19,454↑0.3% | 19,398↑10.1% | 17,619 | |
| Cost of Revenue | 14,599↑0.1% | 14,579↑0.3% | 14,529↑0.2% | 14,504↑12.9% | 12,846 | |
| Gross Profit | 5,029↑5.7% | 4,757↓3.4% | 4,925↑0.6% | 4,894↑2.5% | 4,773 | |
| Operating Expenses | ||||||
| R&D Expenses | 158↓13.9% | 183↓20.9% | 232↑1.5% | 229↑3.6% | 221 | |
| General & Administrative Expenses | 0.00↓100.0% | 2,366↓0.9% | 2,388↑0.8% | 2,369 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 777↓3.9% | 808↑0.9% | 801 | 0.00 | |
| SG&A Expenses | 3,033↓3.5% | 3,143↓1.7% | 3,196↑0.8% | 3,170↑14.3% | 2,773 | |
| Other Expenses | 11↓71.0% | 38↓70.2% | 127↑846.0% | -17↑76.6% | -73 | |
| Operating Expenses | 3,202↓4.8% | 3,364↓5.4% | 3,556↑5.1% | 3,382↑15.8% | 2,921 | |
| Total Costs & Expenses | 17,801↓0.8% | 17,944↓0.8% | 18,084↑1.1% | 17,886↑13.4% | 15,766 | |
| Operating Results | ||||||
| Operating Income | 1,827↑31.2% | 1,392↑1.7% | 1,369↓9.4% | 1,512↓18.4% | 1,852 | |
| Depreciation & Amortization | 1,445↓17.1% | 1,742↓0.6% | 1,752↓4.7% | 1,838↑13.2% | 1,624 | |
| EBITDA | 2,957↓7.8% | 3,206↓0.1% | 3,210↓6.1% | 3,418↓3.7% | 3,549 | |
| EBIT | 1,512↑3.3% | 1,464↑0.4% | 1,458↓7.7% | 1,579↓18.0% | 1,925 | |
| Interest & Other Income | ||||||
| Net Interest Income | -315↑6.2% | -335↑0.3% | -336↓15.0% | -292↓4.3% | -280 | |
| Interest Income | 70↓2.7% | 72↓18.9% | 88↑30.4% | 68↓7.5% | 73 | |
| Interest Expense | 384↓5.6% | 407↓4.1% | 425↑17.9% | 360↑1.8% | 354 | |
| Non-Operating Income | 315↑540.1% | -72↑18.9% | -88↓30.4% | -68↑7.5% | -73 | |
| Other Income / Expenses | -315↑6.1% | -335↑0.3% | -336↓15.0% | -292↓4.3% | -280 | |
| Income Before Tax | 1,512↑43.1% | 1,057↑2.3% | 1,033↓15.3% | 1,219↓22.4% | 1,572 | |
| Income Tax Expense | 321↑1.6% | 316↑5.2% | 301↓7.5% | 325↓7.9% | 353 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 1,191↑60.8% | 741↑1.1% | 732↓18.1% | 894↓26.6% | 1,219 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 978↑81.8% | 538↑7.8% | 499↓25.9% | 673↓30.5% | 969 | |
| Bottom-Line Net Income | 978↑81.8% | 538↑7.8% | 499↓25.9% | 673↓30.5% | 969 | |
| EPS (Basic) | 1.68↑82.6% | 0.92↑8.2% | 0.85↑49.1% | 0.57↓31.3% | 0.83 | |
| EPS (Diluted) | 1.68↑82.6% | 0.92↑8.2% | 0.85↑49.1% | 0.57↓31.3% | 0.83 | |
| Weighted Average Shares | 582↓0.9% | 588↑0.1% | 587↓50.0% | 1,173↑0.1% | 1,172 | |
| Weighted Average Diluted Shares | 582↓0.8% | 587↑0.0% | 587↓50.0% | 1,173↑0.1% | 1,172 | |
* All figures in Millions of EUR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.